News

Moderna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...